CMKLR1 and breast cancer: ChemR23 activation with the agonistic antibody decreased the VEGFA expression by BC TAM-like (Figure S11A), the MMP9 expression by MPM TAM-like and tended to decrease MMP9 expression by BC TAM-like (Figure S11B).